Cargando…

Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis

Detalles Bibliográficos
Autores principales: Kaewdech, Apichat, Pinpathomrat, Nawamin, Chamroonkul, Naichaya, Piratvisuth, Teerha, Sripongpun, Pimsiri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252369/
http://dx.doi.org/10.1016/S0168-8278(22)00750-4
_version_ 1784740248573444096
author Kaewdech, Apichat
Pinpathomrat, Nawamin
Chamroonkul, Naichaya
Piratvisuth, Teerha
Sripongpun, Pimsiri
author_facet Kaewdech, Apichat
Pinpathomrat, Nawamin
Chamroonkul, Naichaya
Piratvisuth, Teerha
Sripongpun, Pimsiri
author_sort Kaewdech, Apichat
collection PubMed
description
format Online
Article
Text
id pubmed-9252369
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92523692022-07-05 Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis Kaewdech, Apichat Pinpathomrat, Nawamin Chamroonkul, Naichaya Piratvisuth, Teerha Sripongpun, Pimsiri J Hepatol POSTER PRESENTATIONS: Thursday 23 June: Immunology European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252369/ http://dx.doi.org/10.1016/S0168-8278(22)00750-4 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER PRESENTATIONS: Thursday 23 June: Immunology
Kaewdech, Apichat
Pinpathomrat, Nawamin
Chamroonkul, Naichaya
Piratvisuth, Teerha
Sripongpun, Pimsiri
Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
title Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
title_full Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
title_fullStr Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
title_full_unstemmed Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
title_short Heterologous SARS-CoV-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
title_sort heterologous sars-cov-2 vaccine triggers more humoral immune responses among patients with liver cirrhosis
topic POSTER PRESENTATIONS: Thursday 23 June: Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252369/
http://dx.doi.org/10.1016/S0168-8278(22)00750-4
work_keys_str_mv AT kaewdechapichat heterologoussarscov2vaccinetriggersmorehumoralimmuneresponsesamongpatientswithlivercirrhosis
AT pinpathomratnawamin heterologoussarscov2vaccinetriggersmorehumoralimmuneresponsesamongpatientswithlivercirrhosis
AT chamroonkulnaichaya heterologoussarscov2vaccinetriggersmorehumoralimmuneresponsesamongpatientswithlivercirrhosis
AT piratvisuthteerha heterologoussarscov2vaccinetriggersmorehumoralimmuneresponsesamongpatientswithlivercirrhosis
AT sripongpunpimsiri heterologoussarscov2vaccinetriggersmorehumoralimmuneresponsesamongpatientswithlivercirrhosis